Embolise
Research payments
$7,775,298
Through program year 2025, $7,775,298 in research payments was reported against Embolise, across 1,185 payments.
- Paid by (largest first)
- Medtronic, Inc.; Medtronic USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $360,923 | 155 |
| 2024 | Research | $1,047,784 | 227 |
| 2023 | Research | $2,765,508 | 300 |
| 2022 | Research | $2,443,049 | 263 |
| 2021 | Research | $1,035,951 | 153 |
| 2020 | Research | $101,713 | 66 |
| 2019 | Research | $20,370 | 21 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jared Knopman New York, NY Named on 61 payments
- Maxim Mokin Tampa, FL Named on 59 payments
- Hakeem Shakir Oklahoma City, OK Named on 27 payments
- Ameer Hassan Harlingen, TX Named on 27 payments
- Jason Tarpley Santa Monica, CA Named on 24 payments
- Irfan Altafullah Minneapolis, MN Named on 23 payments
- Jesse Jones Birmingham, AL Named on 22 payments
- Daniel Hoit Memphis, TN Named on 22 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.